0001104659-23-041747.txt : 20230404
0001104659-23-041747.hdr.sgml : 20230404
20230404201257
ACCESSION NUMBER: 0001104659-23-041747
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dietz Thomas John
CENTRAL INDEX KEY: 0001574218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 23800737
MAIL ADDRESS:
STREET 1: C/O TRANSCEPT PHARMACEUTICAL, INC.
STREET 2: 1003 W. CUTTING BLVD, STE 110
CITY: PT. RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
tm2311741-6_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-03-31
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001574218
Dietz Thomas John
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET SUITE B1-1
CAMBRIDGE
MA
02141
1
0
0
0
0
Stock Option (Right to Buy)
0.34
2023-03-31
4
A
0
175000
0
A
2033-03-31
Common Stock
175000
175000
D
The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.
/s/ Douglas E. Onsi as attorney-in-fact for Thomas Dietz
2023-04-04